Precision oncology is about selecting the right drug or treatment for the right patient at the right time. Exactis Innovation is a pan-Canadian network helping Canadian cancer patients and their clinicians do just that. Since December 2015, the  Personalize My Treatment (PMT)™ initiative has been enrolling cancer patients into a registry that captures the patients’ medical history and the molecular and genomic characteristics of their cancer.

The ultimate goal of the network is to increase the number of precision oncology trials in Canada and to match patients in the registry to these trials. Solving the challenges of matching patients with the right treatment in the clinical research setting will not only attract more trials but importantly, will create greater access for Canadian cancer patients to novel targeted treatments.

Mediaplanet spoke with three clinicians and a key patient group advocate for more insight into the field.


Dr. Helen MacKay

Chair of the Principal Investigator Coordinating Committee, Exactis Innovation & Head of Division of Medical Oncology and Hematology, Sunnybrook Hospital

Dr. Simon Turcotte

Vice Chair of the Principal Investigator Coordinating Committee, Exactis Innovation & Surgical Oncologist, Centre hospitalier de L’Université de Montréal

Barry D. Stein

Member of the Board of Directors, Exactis Innovation & CEO, Colorectal Cancer Canada

Dr. Gerald Batist

Co-founder & Chief Medical Officer, Exactis Innovation & Director, Jewish General Hospital

To learn more visit Exactis or send a message to